Is PVH a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on The PVH+ Plan and the shift toward direct-to-consumer, with q1 fy2026 revenue (13 weeks ended may 3, 2026) at ~$2.03 billion, up ~2% reported and down ~2% in constant currency. The bear case rests on the China listing is the overhang that has no timetable: MOFCOM placed PVH on the List of Unreliable Entities in February 2025 over Xinjiang cotton sourcing, no measures have been imposed as of the report filed in June 2026, and the potential remedies range from fines to bans on importing, exporting or investing in China, in a market supplying roughly 6% of revenue and roughly 20% of pre-impairment operating profit. Analysts covering it are spread from $70.00 to $128.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The China listing is the overhang that has no timetable: MOFCOM placed PVH on the List of Unreliable Entities in February 2025 over Xinjiang cotton sourcing, no measures have been imposed as of the report filed in June 2026, and the potential remedies range from fines to bans on importing, exporting or investing in China, in a market supplying roughly 6% of revenue and roughly 20% of pre-impairment operating profit. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $70.00, -15.1% from the $82.47 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

The PVH+ Plan and the shift toward direct-to-consumer. PVH+ is the multi-year plan to run Calvin Klein and Tommy Hilfiger as demand-driven global brands with regional commercial execution, and the clearest read on whether it is working is the channel split. The most optimistic analyst target on PVH is $128.00, +55.2% from the $82.47 price. That figure is only reachable if this thesis works close to its best case.

The China listing is the overhang that has no timetable: MOFCOM placed PVH on the List of Unreliable Entities in February 2025 over Xinjiang cotton sourcing, no measures have been imposed as of the report filed in June 2026, and the potential remedies range from fines to bans on importing, exporting or investing in China, in a market supplying roughly 6% of revenue and roughly 20% of pre-impairment operating profit. EMEA, at about half of group revenue, was the reason full-year guidance came down in June 2026, with first-quarter EMEA revenue off ~5% in constant currency on the prolonged effects of the Middle East conflict. Tariff exposure is both large and unsettled: the outlook assumes a ~15% blended rate and a ~$195 million gross hit, and the company describes the offsetting ~$100 million of refunds as uncertain in amount and timing and dependent on processes outside its control, with the rate itself in flux after the Supreme Court ruling and the subsequent Section 122 executive order. The balance sheet leaves less room than the multiple suggests, with ~$2.28 billion of debt against ~$593 million of cash and a further ~$1.9 billion of operating lease liabilities on a ~$3.8 billion market capitalisation. Finally, after the June 3, 2026 guidance cut and a same-week analyst downgrade, several plaintiff firms including Schall, Bronstein Gewirtz & Grossman and Levi & Korsinsky publicly announced investigations into whether PVH misled investors; as of mid-August 2026 no securities class action complaint with a case number has been identified and PVH's own filings describe only ordinary-course litigation, and the chief financial officer post is currently held on an interim basis. The most pessimistic published target is $70.00, -15.1% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Owns Tommy Hilfiger and Calvin Klein, designing and selling apparel, footwear and accessories worldwide, alongside a smaller Heritage Brands business.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (The PVH+ Plan and the shift toward direct-to-consumer) stalling in the reported numbers rather than in the narrative, the risk above (the China listing is the overhang that has no timetable: MOFCOM placed PVH on the List of Unreliable Entities in February 2025 over Xinjiang cotton sourcing, no measures have been imposed as of the report filed in June 2026, and the potential remedies range from fines to bans on importing, exporting or investing in China, in a market supplying roughly 6% of revenue and roughly 20% of pre-impairment operating profit) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

PVH owns two brands outright, TOMMY HILFIGER and Calvin Klein, and they produced over 95% of fiscal 2025 revenue. The rest is the Heritage Brands business, roughly ~$215 million, where PVH licenses names such as Van Heusen and Nike from third parties for particular categories. The old Heritage portfolio has largely been sold off: the Van Heusen and related men's business went in 2021 and the Warner's, Olga and True&Co intimates business was sold in November 2023, which is why PVH today is essentially a two-brand company.

Yes. MOFCOM opened its investigation in September 2024, issued a preliminary finding in January 2025 that PVH had violated normal market trading principles, and placed the company on the List of Unreliable Entities in February 2025 over its handling of Xinjiang cotton sourcing. In the quarterly report filed on June 5, 2026, PVH stated that it remains on the list, that it does not know if or when MOFCOM will implement any measures, and that no measures have been imposed to date. Potential measures under the UEL Provisions include fines, restrictions on import, export or investment activity in China, and entry or work-permit restrictions on personnel, so the overhang is unresolved rather than cleared.

Three things compress the multiple at once. Operating margin is thin, at ~8.8% on a non-GAAP basis and only ~2.6% on a GAAP basis in fiscal 2025 after a ~$480 million impairment. Roughly half of revenue comes from EMEA, where the outlook was cut in June 2026, and about 6% of revenue plus about 20% of pre-impairment operating profit comes from a China business under an unresolved government listing. Layer on ~$1.7 billion of net debt and ~$1.9 billion of lease liabilities against a ~$3.8 billion market value and the equity is a fairly small slice of a leveraged, geopolitically exposed enterprise, which is what the ~0.4x sales multiple is expressing.